BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32878779)

  • 1. New Imidazo[2,1-
    Li Petri G; Pecoraro C; Randazzo O; Zoppi S; Cascioferro SM; Parrino B; Carbone D; El Hassouni B; Cavazzoni A; Zaffaroni N; Cirrincione G; Diana P; Peters GJ; Giovannetti E
    Anticancer Res; 2020 Sep; 40(9):4913-4919. PubMed ID: 32878779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.
    Cascioferro S; Petri GL; Parrino B; Carbone D; Funel N; Bergonzini C; Mantini G; Dekker H; Geerke D; Peters GJ; Cirrincione G; Giovannetti E; Diana P
    Eur J Med Chem; 2020 Mar; 189():112088. PubMed ID: 32007666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives.
    Kumar S; Gopalakrishnan V; Hegde M; Rana V; Dhepe SS; Ramareddy SA; Leoni A; Locatelli A; Morigi R; Rambaldi M; Srivastava M; Raghavan SC; Karki SS
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4682-4688. PubMed ID: 25205189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds.
    Romagnoli R; Baraldi PG; Prencipe F; Balzarini J; Liekens S; Estévez F
    Eur J Med Chem; 2015 Aug; 101():205-17. PubMed ID: 26141911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1.
    Giovannetti E; Leon LG; Gómez VE; Zucali PA; Minutolo F; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):643-651. PubMed ID: 27906635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
    Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
    Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds.
    Avvaru SP; Noolvi MN; More UA; Chakraborty S; Dash A; Aminabhavi TM; Narayan KP; Sutariya V
    Med Chem; 2021; 17(7):750-765. PubMed ID: 32427086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.
    Serova M; Galmarini CM; Ghoul A; Benhadji K; Green SR; Chiao J; Faivre S; Cvitkovic E; Le Tourneau C; Calvo F; Raymond E
    Br J Cancer; 2007 Sep; 97(5):628-36. PubMed ID: 17637678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.
    Avan A; Crea F; Paolicchi E; Funel N; Galvani E; Marquez VE; Honeywell RJ; Danesi R; Peters GJ; Giovannetti E
    Mol Cancer Ther; 2012 Aug; 11(8):1735-46. PubMed ID: 22622284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Molecular Docking Screening and Anti-Proliferative Potency Evaluation of Some New Imidazo[2,1-
    Rashdan HRM; Abdelmonsef AH; Shehadi IA; Gomha SM; Soliman AMM; Mahmoud HK
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1.
    Wang H; Word BR; Lyn-Cook BD
    Anticancer Res; 2011 Oct; 31(10):3171-80. PubMed ID: 21965724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.
    Kumar S; Hegde M; Gopalakrishnan V; Renuka VK; Ramareddy SA; De Clercq E; Schols D; Gudibabande Narasimhamurthy AK; Raghavan SC; Karki SS
    Eur J Med Chem; 2014 Sep; 84():687-97. PubMed ID: 25064346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human equilibrative nucleoside transporter-1 and deoxycytidine kinase can predict gemcitabine effectiveness in Egyptian patients with Hepatocellular carcinoma.
    Attia F; Fathy S; Anani M; Hassan A; Attia F; Ibrahim G; Elazab M
    J Clin Lab Anal; 2020 Nov; 34(11):e23457. PubMed ID: 32671914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
    Giovannetti E; Mey V; Loni L; Nannizzi S; Barsanti G; Savarino G; Ricciardi S; Del Tacca M; Danesi R
    Pharmacol Res; 2007 Apr; 55(4):343-9. PubMed ID: 17296311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
    Brandi G; Deserti M; Vasuri F; Farioli A; Degiovanni A; Palloni A; Frega G; Barbera MA; de Lorenzo S; Garajova I; Di Marco M; Pinna AD; Cescon M; Cucchetti A; Ercolani G; D'Errico-Grigioni A; Pantaleo MA; Biasco G; Tavolari S;
    Oncologist; 2016 May; 21(5):600-7. PubMed ID: 27032872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
    Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
    Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SYNTHESIS OF IMIDAZO[2,1-b][1,3,4]THIADIAZOLE DERIVATIVES AS POSSIBLE BIOLOGICALLY ACTIVE AGENTS.
    Kumar S; Metikurki B; Bhadauria VS; Clercq E; Schols D; Tokuda H; Karki SS
    Acta Pol Pharm; 2016 Jul; 73(4):913-929. PubMed ID: 29648717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
    Mey V; Giovannetti E; De Braud F; Nannizzi S; Curigliano G; Verweij F; De Cobelli O; Pece S; Del Tacca M; Danesi R
    Br J Cancer; 2006 Aug; 95(3):289-97. PubMed ID: 16868547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of imidazo-thiadiazole linked indolinone conjugates and evaluated their microtubule network disrupting and apoptosis inducing ability.
    Narasimha Rao MP; Nagaraju B; Kovvuri J; Polepalli S; Alavala S; Vishnuvardhan MVPS; Swapna P; Nimbarte VD; Lakshmi JK; Jain N; Kamal A
    Bioorg Chem; 2018 Feb; 76():420-436. PubMed ID: 29275261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.